Literature DB >> 24262502

Renal flare as a predictor of incident and progressive CKD in patients with lupus nephritis.

Samir V Parikh1, Haikady N Nagaraja, Lee Hebert, Brad H Rovin.   

Abstract

BACKGROUND AND OBJECTIVES: Renal flares are common in lupus nephritis. The impact of flares on the development of CKD in lupus nephritis was examined. DESIGN, SETTING, PARTICIPANTS, & MEASUREMENTS: A retrospective analysis of prospectively collected data from the Ohio Systemic Lupus Erythematosus (SLE) Study was conducted to determine if renal flares predispose to new CKD or progression of preexisting CKD. Patients in the Ohio SLE Study were followed from 2001 to 2009, with a median follow-up of 6 years. For this analysis, patients with biopsy-proven lupus nephritis and at least 3 years of follow-up were included (n=56). Frequency and duration of renal flares were compared between patients who never developed CKD (n=29) and patients who developed new CKD (n=12) and between patients with preexisting but stable CKD (n=7) and patients who progressed (n=8). Groups were also combined into good (no CKD and stable CKD) or poor (new CKD and progressive CKD) for analysis.
RESULTS: The new CKD group had more renal flares per year compared with the no CKD group (median=0.56 flares/yr [range=0-2] versus median=0 flares/yr [range=0-1.4]; P<0.001). Additionally, the poor outcome group had more renal flares per year compared with the good outcome group (median=0.50 flares/yr [range=0-2] versus median=0 flares/yr [range=0-1.4]; P<0.001). New or progressive CKD was not preferentially associated with nephritic compared with proteinuric renal flares. Logistic regression showed that spending more than 30% of time in renal flare (odds ratio, 20; 95% confidence interval, 4.6 to 91.3; P<0.001) and age>35 years (odds ratio, 69; 95% confidence interval, 6.3 to 753.6; P<0.001) were independent predictors of the combined end point of developing new or progressive CKD. All four subjects over 35 years of age that spent over 30% of time in renal flare had a poor outcome.
CONCLUSION: In patients with lupus nephritis, the relative duration of renal flare is an independent predictor of incident and progressive CKD.

Entities:  

Mesh:

Year:  2013        PMID: 24262502      PMCID: PMC3913239          DOI: 10.2215/CJN.05040513

Source DB:  PubMed          Journal:  Clin J Am Soc Nephrol        ISSN: 1555-9041            Impact factor:   8.237


  13 in total

1.  Renal flares in 91 SLE patients with diffuse proliferative glomerulonephritis.

Authors:  Marta Mosca; Walter Bencivelli; Rossella Neri; Antonio Pasquariello; Valentina Batini; Rodolfo Puccini; Antonio Tavoni; Stefano Bombardieri
Journal:  Kidney Int       Date:  2002-04       Impact factor: 10.612

2.  Renal flares are common in patients with severe proliferative lupus nephritis treated with pulse immunosuppressive therapy: long-term followup of a cohort of 145 patients participating in randomized controlled studies.

Authors:  G G Illei; K Takada; D Parkin; H A Austin; M Crane; C H Yarboro; E M Vaughan; T Kuroiwa; C L Danning; J Pando; A D Steinberg; M F Gourley; J H Klippel; J E Balow; D T Boumpas
Journal:  Arthritis Rheum       Date:  2002-04

3.  Urine chemokines as biomarkers of human systemic lupus erythematosus activity.

Authors:  Brad H Rovin; Huijuan Song; Dan J Birmingham; Lee A Hebert; Chack Yung Yu; Haikady N Nagaraja
Journal:  J Am Soc Nephrol       Date:  2004-12-15       Impact factor: 10.121

4.  "Nephritic flares" are predictors of bad long-term renal outcome in lupus nephritis.

Authors:  G Moroni; S Quaglini; M Maccario; G Banfi; C Ponticelli
Journal:  Kidney Int       Date:  1996-12       Impact factor: 10.612

5.  Relationship between appearance of urinary red blood cell/white blood cell casts and the onset of renal relapse in systemic lupus erythematosus.

Authors:  L A Hebert; J J Dillon; D F Middendorf; E J Lewis; J B Peter
Journal:  Am J Kidney Dis       Date:  1995-09       Impact factor: 8.860

6.  Predictors and outcome of renal flares after successful cyclophosphamide treatment for diffuse proliferative lupus glomerulonephritis.

Authors:  Chi Chiu Mok; King Yee Ying; Sydney Tang; Chung Ying Leung; Ka Wing Lee; Woon Leung Ng; Raymond Woon Sing Wong; Chak Sing Lau
Journal:  Arthritis Rheum       Date:  2004-08

Review 7.  Biomarker discovery in human SLE nephritis.

Authors:  Brad H Rovin; Daniel J Birmingham; Haikady N Nagaraja; C Yung Yu; Lee A Hebert
Journal:  Bull NYU Hosp Jt Dis       Date:  2007

8.  Dialysis-requiring acute renal failure increases the risk of progressive chronic kidney disease.

Authors:  Lowell J Lo; Alan S Go; Glenn M Chertow; Charles E McCulloch; Dongjie Fan; Juan D Ordoñez; Chi-yuan Hsu
Journal:  Kidney Int       Date:  2009-07-29       Impact factor: 10.612

9.  Joint European League Against Rheumatism and European Renal Association-European Dialysis and Transplant Association (EULAR/ERA-EDTA) recommendations for the management of adult and paediatric lupus nephritis.

Authors:  George K Bertsias; Maria Tektonidou; Zahir Amoura; Martin Aringer; Ingeborg Bajema; Jo H M Berden; John Boletis; Ricard Cervera; Thomas Dörner; Andrea Doria; Franco Ferrario; Jürgen Floege; Frederic A Houssiau; John P A Ioannidis; David A Isenberg; Cees G M Kallenberg; Liz Lightstone; Stephen D Marks; Alberto Martini; Gabriela Moroni; Irmgard Neumann; Manuel Praga; Matthias Schneider; Argyre Starra; Vladimir Tesar; Carlos Vasconcelos; Ronald F van Vollenhoven; Helena Zakharova; Marion Haubitz; Caroline Gordon; David Jayne; Dimitrios T Boumpas
Journal:  Ann Rheum Dis       Date:  2012-07-31       Impact factor: 19.103

10.  Acute kidney injury increases risk of ESRD among elderly.

Authors:  Areef Ishani; Jay L Xue; Jonathan Himmelfarb; Paul W Eggers; Paul L Kimmel; Bruce A Molitoris; Allan J Collins
Journal:  J Am Soc Nephrol       Date:  2008-11-19       Impact factor: 14.978

View more
  27 in total

1.  Investigation on the benefits of mycophenolate mofetil and therapeutic drug monitoring in the treatment of Japanese patients with lupus nephritis.

Authors:  Takayuki Katsuno; Takenori Ozaki; Takaya Ozeki; Asaka Hachiya; Hangsoo Kim; Noritoshi Kato; Takuji Ishimoto; Sawako Kato; Tomoki Kosugi; Naotake Tsuboi; Masashi Mizuno; Yasuhiko Ito; Shoichi Maruyama
Journal:  Clin Exp Nephrol       Date:  2018-05-23       Impact factor: 2.801

2.  Immune gene expression in kidney biopsies of lupus nephritis patients at diagnosis and at renal flare.

Authors:  Juan M Mejia-Vilet; Samir V Parikh; Huijuan Song; Paolo Fadda; John P Shapiro; Isabelle Ayoub; Lianbo Yu; Jianying Zhang; Norma Uribe-Uribe; Brad H Rovin
Journal:  Nephrol Dial Transplant       Date:  2019-07-01       Impact factor: 5.992

Review 3.  Lupus nephritis: the evolving role of novel therapeutics.

Authors:  Brad H Rovin; Samir V Parikh
Journal:  Am J Kidney Dis       Date:  2014-01-07       Impact factor: 8.860

4.  Diagnostic value of progranulin in patients with lupus nephritis and its correlation with disease activity.

Authors:  Jiabin Wu; Lixin Wei; Weiming Wang; Xianghui Zhang; Li Chen; Changda Lin
Journal:  Rheumatol Int       Date:  2016-03-11       Impact factor: 2.631

Review 5.  Proteomic profiling of urine: implications for lupus nephritis.

Authors:  Najla Aljaberi; Michael Bennett; Hermine I Brunner; Prasad Devarajan
Journal:  Expert Rev Proteomics       Date:  2019-03-18       Impact factor: 3.940

6.  Analysis of clinical risk factors in relapsed patients with class IV lupus nephritis.

Authors:  Jing Wang; Yuan-Yuan Qi; Xue-Ping Chen; Li Ma; Li-Li Zhang; Yu Zhao; Mei Wang
Journal:  Exp Ther Med       Date:  2018-05-03       Impact factor: 2.447

Review 7.  Update on Lupus Nephritis.

Authors:  Salem Almaani; Alexa Meara; Brad H Rovin
Journal:  Clin J Am Soc Nephrol       Date:  2016-11-07       Impact factor: 8.237

Review 8.  Lupus nephritis.

Authors:  Hans-Joachim Anders; Ramesh Saxena; Ming-Hui Zhao; Ioannis Parodis; Jane E Salmon; Chandra Mohan
Journal:  Nat Rev Dis Primers       Date:  2020-01-23       Impact factor: 52.329

Review 9.  What is damaging the kidney in lupus nephritis?

Authors:  Anne Davidson
Journal:  Nat Rev Rheumatol       Date:  2015-11-19       Impact factor: 20.543

10.  Histologic versus clinical remission in proliferative lupus nephritis.

Authors:  Ana Malvar; Paola Pirruccio; Valeria Alberton; Bruno Lococo; Cecilia Recalde; Bernanda Fazini; Haikady Nagaraja; Divya Indrakanti; Brad H Rovin
Journal:  Nephrol Dial Transplant       Date:  2017-08-01       Impact factor: 5.992

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.